Skip to content
FrontierPicks

· an extra edition, outside the schedule

Change feed · last 30 days

Everything that changed.

Changes as of

Each day opens with a one-line summary. The portfolio's changes, the market regime, rating changes on its holdings and moves into or out of High are listed one by one, with the research note's reason; routine rating moves and re-reads are folded under their count.

Ratings are High, Medium or Low, and a rating can change whenever its note is re-read: 17 stocks read first, re-read at least every four days; all 1,125 within 5 sessions. A rating change is a move between two ratings on a stock the research covers; a first rating is not one, and a stock no longer covered is not counted. A move whose note stated no reason is listed and says so. The last seven days in one page: this week in US stocks →

1 other rating change · 18 notes re-read.

1 raised to Medium
18 research notes last re-read this day

2 other rating changes · 47 notes re-read.

Week in review The week in US stocks and what to watch next week
2 cut to Low
47 research notes last re-read this day

The portfolio added to LLY and bought IMAX · 24 new research notes · 2 themes changed stage · 2 other rating changes · 19 first ratings · 349 notes re-read.

IMAX Bought for the portfolio (results) LLY Eli Lilly Added to in the portfolio (company news) Market read Regime: neutral, unchanged Ad tech & digital advertising Theme moved from maturing to saturated Travel & leisure Theme moved from accelerating to maturing AAL American Airlines Group New research note ADMA ADMA Biologics New research note ALGT Allegiant Travel New research note AMGN Amgen New research note AXP American Express New research note AZO AutoZone New research note BETR Better Home & Finance Holding New research note BSX Boston Scientific New research note BZ Kanzhun New research note C Citigroup New research note CHA Chagee Holdings New research note COP ConocoPhillips New research note CRSP CRISPR Therapeutics New research note CTO CTO Realty Growth New research note CVS CVS Health New research note DASH DoorDash New research note DE Deere New research note ENVX Enovix New research note ET Energy Transfer LP Common Units New research note MBGL Mobility Global New research note NIO New research note NU Nu Holdings New research note SOUN SoundHound AI New research note VYX NCR Voyix New research note
2 cut to Low
15 first rated Low
4 first rated Medium
11 joined the momentum board
349 research notes last re-read this day

The portfolio bought CHYM, ETON, QNST and XERS · Market regime changed from risk-on to neutral · 22 new research notes · 37 other rating changes · 4 first ratings · 503 notes re-read.

CHYM Chime Financial Bought for the portfolio (results) ETON Eton Pharmaceuticals Bought for the portfolio (results) QNST QuinStreet Bought for the portfolio (results) XERS Xeris Biopharma Holdings Bought for the portfolio (results) Market regime Changed from risk-on to neutral AVEX AEVEX New research note BRUN Boost Run New research note CAPR Capricor Therapeutics New research note CARS Cars.com New research note CBRS Cerebras Systems New research note CLVT Clarivate New research note CRMD CorMedix New research note CTVA Corteva New research note CVNA Carvana New research note FIGR Figure Technology Solutions New research note FRMI Fermi New research note FRVO Fervo Energy New research note HUBS HubSpot New research note NBTX Nanobiotix New research note PZZA Papa John's International New research note RDDT Reddit New research note REZI Resideo Technologies New research note TE T1 Energy New research note TTEK Tetra Tech New research note UPST Upstart Holdings New research note XE X-Energy New research note ZM Zoom Communications New research note
27 raised to Medium
10 cut to Low
2 first rated Medium
2 first rated Low
503 research notes last re-read this day

The portfolio bought PLMR and ZETA · Market regime changed from neutral to risk-on · 1 holding re-rated (MSFT cut to Medium) · AZTA raised to High and STRL cut to Medium · 4 new research notes · 53 other rating changes · 1 first rating · 121 notes re-read.

PLMR Palomar Holdings Bought for the portfolio (results) ZETA Zeta Global Holdings Bought for the portfolio (results) MSFT Microsoft Rating cut from High to Medium Company news, 10 November 2026: Anthropic launched Claude Sheets, a spreadsheet that competes with Excel, alongside Claude Data and Claude Whiteboards; Microsoft shares fell as much as 3% intraday and closed down 2.2% at $533.16.

This names Anthropic, the company that makes Claude, the AI model that wrote it. The conflict of interest, stated.

AZTA Azenta Rating raised from Medium to High Results, 10 November 2026: Azenta beat its fourth-quarter revenue outlook and guided fiscal 2027 revenue to $648M-$660M against a $639.3M consensus, with adjusted EBITDA margin up 200 to 250 basis points. STRL Sterling Infrastructure Rating cut from High to Medium The note's kill line was crossed, 10 November 2026: The shares closed at $289.56 on 10 November 2026, below the $340 kill line in the previous note, with no company filing or guidance change to explain the fall from the $388.87 close on 28 October 2026. Market regime Changed from neutral to risk-on AGLT Churchill Capital Corp XI New research note IRON Disc Medicine New research note NXH Bed Bath & Beyond New research note QUIT Achieve Life Sciences New research note
34 raised to Medium
19 cut to Low
1 first rated Medium
121 research notes last re-read this day

The portfolio bought APPN, KNSA, LLY, MSFT and U · 4 new research notes · 58 first ratings · 33 notes re-read.

APPN Appian Bought in the portfolio's opening purchases KNSA Kiniksa Pharmaceuticals International Bought in the portfolio's opening purchases LLY Eli Lilly Bought in the portfolio's opening purchases MSFT Microsoft Bought in the portfolio's opening purchases U Unity Software Bought in the portfolio's opening purchases Market read Regime: neutral APP AppLovin New research note CDRE Cadre Holdings New research note COOK Traeger New research note RDAC Rising Dragon Acquisition New research note
50 first rated Medium
8 first rated Low
33 research notes last re-read this day